Infant Acute Lymphoblastic Leukemia: Past Experience and Future Therapy
Pediatric pharmacology · 31.05.2026 · 23 (2) · 72-80
DOI: 10.15690/pf.v23i2.3031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric pharmacology, online erschienen am 31.05.2026. Verfasst von Maria D. Efremova und 1 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
Infant acute lymphoblastic leukemia (ALL) is a rare and biologically unique form of hematologic malignancy occurring in children during the first year of life. It is characterized by an aggressive clinical course and unfavorable prognosis, particularly in the presence of KMT2A gene rearrangements. This article provides a review of current data on the clinical, immunological, and molecular-genetic features of B-cell precursor infant ALL. The mechanisms of epigenetic dysregulation and potential targets for targeted therapy are discussed in detail. The evolution of risk stratification approaches, the role of minimal residual disease, and the results of international collaborative studies aimed at improving treatment outcomes are reviewed. Particular attention is paid to the introduction of immunotherapeutic agents — blinatumomab and chimeric antigen receptor T-cells (CAR-T) — and their efficacy in disease control. The limited role of hematopoietic stem cell transplantation and current trends toward narrowing its indications are discussed. In conclusion, the importance of integrating genetic and dynamically changing laboratory parameters for treatment personalization is emphasized, and future perspectives for further improving outcomes in infants with this disease are outlined.
Zitieren
APA
Efremova, M. D., & Valiev, T. T. (2026). Infant Acute Lymphoblastic Leukemia: Past Experience and Future Therapy. Pediatric pharmacology, 23(2), 72-80. https://doi.org/10.15690/pf.v23i2.3031
Vancouver
Efremova MD, Valiev TT. Infant Acute Lymphoblastic Leukemia: Past Experience and Future Therapy. Pediatric pharmacology. 2026;23(2):72-80. doi:10.15690/pf.v23i2.3031
BibTeX
@article{Efremova2026,
author = {Efremova, Maria D. and Valiev, Timur T.},
title = {Infant Acute Lymphoblastic Leukemia: Past Experience and Future Therapy},
journal = {Pediatric pharmacology},
year = {2026},
volume = {23},
number = {2},
pages = {72--80},
doi = {10.15690/pf.v23i2.3031}
}
EUVIMED